Navigation Links
Global Generic Drugs Market - New Industry Research Report Is Now Available for Pre-Order at Transparency Market Research
Date:8/21/2013

Albany, New York (PRWEB) August 21, 2013

The generic drugs industry comprises of the manufacture and marketing of certain drugs which have the same active ingredients as the brand-name drugs manufactured by any pharmaceutical company. The major benefit of generic drugs is that the cost of such drugs is much less than that of branded drugs.

Generic drugs come under the same governing framework as that of the brand-name drugs. The rationale behind generic drugs is that the patented drugs generally have a patent life of 20 years. However, the patent life of such drugs begins from the clinical trials and thus their commercial life is far less (approximately 15 years). After the patent expiry, the manufacturers of such drugs face intense pricing pressure because of the competition from their cheap generic counterparts.

Related Report : Anti-Infectives Market
http://www.transparencymarketresearch.com/anti-infectives-market.html

Sale of generic drugs also holds importance for entities such as wholesalers, pharmacies, and pharmacy benefit managers, as the sale of generic drugs provides higher profit margins than the sale of branded drugs. The generic drugs market is classified as simple generics, super-generics and biosimilars. Furthermore, the generic drugs market can be classified on the basis of their therapeutic applications such as anti-infective drugs, central nervous system drugs, cardiovascular products, anti-arthritis drugs, respiratory products, anti-cancer drugs and others. Geographically, North America is the largest consumer and manufacturer of generic drugs. In addition, the highest growth in this market is observed in Asia-Pacific.

Related Report : Aptamers Market
http://www.transparencymarketresearch.com/aptamers-market.html

Some of the major generic drugs manufacturers include pharmaceutical companies such as Dr. Reddy’s Laboratories, Actavis, Mylan, Inc., Apotex, Inc., Ranbaxy Laboratories, Ltd, Hospira, Inc., Par Pharmaceutical, Inc., Sandoz International GmbH, Teva Pharmaceutical Industries, Ltd., Watson Pharmaceuticals, Ltd. and others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
North America
Asia Pacific
Europe
Rest of the World

Browse Blog : http://market-research-firm.blogspot.com

This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Browse the report with Request TOC at http://www.transparencymarketresearch.com/generic-drugs-market.html

Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a technological growth map over time to understand the industry growth rate
It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
It provides distinctive graphics and exemplified SWOT analysis of major market segments

Browse all Market Research reports: http://www.transparencymarketresearch.com

Read the full story at http://www.prweb.com/releases/2013/8/prweb11047508.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. BCC Research Publishes a New Report On Global Markets for Surveillance and Monitoring of Explosive, Chemical, Biological, and Nuclear (Ecbn) Hazards.
2. Global Ultrasound Devices Market Worth $8.1 Billion by 2017 at a 6.2% CAGR - New Report by MarketsandMarkets
3. Global Cyber Security Market to Reach $120.1 Billion by 2017 at a 11.3% CAGR - New Report by MarketsandMarkets
4. Global Biopesticides Market to Reach $3.2 Billion by 2017 at a 15.8% CAGR - New Report by MarketsandMarkets
5. LDM Global Launches Managed Service, Provides Clients Increased Control, Reduced Cost, Low Risk
6. Global Haircare Industry Discussed by MarketLine in Insightful Report Now Available at MarketPublishers.com
7. Global and China Medical MRI Equipment Industry 2013 SWOT Analysis in New Research Report at RnRMarketResearch.com
8. Global Javlor (Bladder Cancer) Market - Worldwide Industry Share, Size, Players, Opportunity, Analysis and Forecasts to 2020
9. Global X-Ray Market Research Report Published By Transparency Market Research
10. Global Cosmeceuticals Products Market (Topical, Injectable) 2017 Forecasts in a Research Report Available at ReportsnReports.com
11. Water Researcher Praises Jay-Z, Urges Others to Become Involved with Global Water Crisis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of ... its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his ... July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical ... the primary prevention of cardiovascular diseases during the 15th Annual Women’s Health ...
(Date:10/13/2017)... LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for care ... is the 90-day elimination period, when the family pays for care, is often waived, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th ... Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, ... The fun run is geared towards children of all ages; it is a non-competitive, ...
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 ... performance ratings for global supply chains, has published the first annual edition ... CSR performance of more than 20,400 companies evaluated by EcoVadis, based on ... 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
(Date:9/12/2017)... 2017  ValGenesis Inc., the global leader in ... to announce the appointment of Dr. Ajaz ... of Directors and Chairman of Advisory Board beginning ... companies to manage their entire validation lifecycle process ... this process. Furthermore, ValGenesis VLMS enables rigorous compliance, ...
Breaking Medicine Technology: